US Chemical Technologies has filed a notice of an exempt offering of securities to raise $29,999,977.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, US Chemical Technologies is raising up to $29,999,977.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About US Chemical Technologies
US Chemical Technologies (USCT) is a next-generation supplier of critical specialty materials and chemicals focused on Aerospace & Defense. The company says it is committed to strengthening the U.S. industrial base by safeguarding and advancing the materials and processes that support American aerospace and defense needs. It describes itself as a permanent capital operating company, emphasizing long-term stewardship rather than short-term value extraction. USCT also highlights that its team has deep roots in Aerospace & Defense and Industrials, and that customers receive hands-on support from experienced operators. The page lists a leadership team that includes Dan DePaoli as Chief Executive Officer, David Glickman as Chief Financial Officer, Jonathan Crandall as Chief Operating Officer, Chris Sahagun as Chief Technology Officer, Lisa Kemp as Head of Research & Development, and Tom Glinski as Head of Corporate Development.
To learn more, visit https://www.uschem.tech/
Contact:
Daniel Depaoli, Chief Executive Officer
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
